Baker Bros. Advisors (Gp) Llc
Director at Kodiak Sciences Inc. (KOD); 10% Owner at Entrada Therapeutics, Inc. (TRDA)
Purchase track record
Not enough history. Based on 1 purchase with a full 90 days of price history.
—
Avg. 90-day return+35.1%
vs. S&P 500+33.5%
Beat the market100%
Paper profit on buys+$21.7M
Total bought / sold$60.0M / $0
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 30SEC | KODKodiak Sciences Inc. | Buy | 8561,561,270 held (+0%) | $61.21 | $52K | +63.2% |
| Sep 30SEC | KODKodiak Sciences Inc. | Buy | 14,34418,373,116 held (+0%) | $61.21 | $878K | +63.2% |
| Sep 30SEC | KODKodiak Sciences Inc. | Buy | 2,6661,563,936 held (+0%) | $61.63 | $164K | +62.0% |
| Sep 30SEC | KODKodiak Sciences Inc. | Buy | 44,69018,417,806 held (+0%) | $61.63 | $2.8M | +62.0% |
| Sep 30SEC | KODKodiak Sciences Inc. | Buy | 2431,564,179 held (+0%) | $62.96 | $15K | +58.6% |
| Sep 30SEC | KODKodiak Sciences Inc. | Buy | 4,06718,421,873 held (+0%) | $62.96 | $256K | +58.6% |
| Sep 30SEC | KODKodiak Sciences Inc. | Buy | 4791,564,658 held (+0%) | $64.43 | $31K | +55.0% |
| Sep 30SEC | KODKodiak Sciences Inc. | Buy | 8,02118,429,894 held (+0%) | $64.43 | $517K | +55.0% |
| Sep 30SEC | KODKodiak Sciences Inc. | Buy | 3211,564,979 held (+0%) | $67.10 | $22K | +48.8% |
| Sep 30SEC | KODKodiak Sciences Inc. | Buy | 5,38218,435,276 held (+0%) | $67.10 | $361K | +48.8% |
| Sep 30SEC | KODKodiak Sciences Inc. | Buy | 1541,565,133 held (+0%) | $68.37 | $11K | +46.1% |
| Sep 30SEC | KODKodiak Sciences Inc. | Buy | 2,58518,437,861 held (+0%) | $68.37 | $177K | +46.1% |
| Sep 30SEC | KODKodiak Sciences Inc. | Buy | 2,3311,567,464 held (+0%) | $68.96 | $161K | +44.8% |
| Sep 30SEC | KODKodiak Sciences Inc. | Buy | 39,06618,476,927 held (+0%) | $68.96 | $2.7M | +44.8% |
| Sep 30SEC | KODKodiak Sciences Inc. | Buy | 1,0561,568,520 held (+0%) | $71.48 | $75K | +39.7% |
| Sep 30SEC | KODKodiak Sciences Inc. | Buy | 17,69818,494,625 held (+0%) | $71.48 | $1.3M | +39.7% |
| Sep 30SEC | KODKodiak Sciences Inc. | Buy | 16,6411,585,161 held (+1%) | $72.39 | $1.2M | +38.0% |
| Sep 30SEC | KODKodiak Sciences Inc. | Buy | 278,97818,773,603 held (+2%) | $72.39 | $20.2M | +38.0% |
| Sep 30SEC | KODKodiak Sciences Inc. | Buy | 4,6961,589,857 held (+0%) | $73.08 | $343K | +36.7% |
| Sep 30SEC | KODKodiak Sciences Inc. | Buy | 78,72618,852,329 held (+0%) | $73.08 | $5.8M | +36.7% |
| Sep 30SEC | KODKodiak Sciences Inc. | Buy | 4,5771,594,434 held (+0%) | $73.97 | $339K | +35.0% |
| Sep 30SEC | KODKodiak Sciences Inc. | Buy | 76,72318,929,052 held (+0%) | $73.97 | $5.7M | +35.0% |
| Sep 30SEC | KODKodiak Sciences Inc. | Buy | 1,9241,596,358 held (+0%) | $75.52 | $145K | +32.2% |
| Sep 30SEC | KODKodiak Sciences Inc. | Buy | 32,26118,961,313 held (+0%) | $75.52 | $2.4M | +32.2% |
| Sep 30SEC | KODKodiak Sciences Inc. | Buy | 3,6811,600,039 held (+0%) | $76.35 | $281K | +30.8% |
| Sep 30SEC | KODKodiak Sciences Inc. | Buy | 61,70019,023,013 held (+0%) | $76.35 | $4.7M | +30.8% |
| Sep 30SEC | KODKodiak Sciences Inc. | Buy | 2,8841,602,923 held (+0%) | $77.43 | $223K | +29.0% |
| Sep 30SEC | KODKodiak Sciences Inc. | Buy | 48,35019,071,363 held (+0%) | $77.43 | $3.7M | +29.0% |
| Sep 30SEC | KODKodiak Sciences Inc. | Buy | 2,9691,605,892 held (+0%) | $78.57 | $233K | +27.1% |
| Sep 30SEC | KODKodiak Sciences Inc. | Buy | 49,77119,121,134 held (+0%) | $78.57 | $3.9M | +27.1% |
| Nov 12SEC | TRDAEntrada Therapeutics, Inc. | Buy | 2,296366,457 held (+1%) | $7.21 | $17K | -21.4% |
| Nov 12SEC | TRDAEntrada Therapeutics, Inc. | Buy | 25,3644,527,022 held (+1%) | $7.21 | $183K | -21.4% |
| Nov 12SEC | TRDAEntrada Therapeutics, Inc. | Buy | 267366,724 held (+0%) | $7.22 | $2K | -21.5% |
| Nov 12SEC | TRDAEntrada Therapeutics, Inc. | Buy | 2,9474,529,969 held (+0%) | $7.22 | $21K | -21.5% |
| Nov 12SEC | TRDAEntrada Therapeutics, Inc. | Buy | 1,059367,783 held (+0%) | $7.39 | $8K | -23.3% |
| Nov 12SEC | TRDAEntrada Therapeutics, Inc. | Buy | 11,7014,541,670 held (+0%) | $7.39 | $86K | -23.3% |
| Nov 12SEC | TRDAEntrada Therapeutics, Inc. | Buy | 2,795370,578 held (+1%) | $7.54 | $21K | -24.8% |
| Nov 12SEC | TRDAEntrada Therapeutics, Inc. | Buy | 30,8794,572,549 held (+1%) | $7.54 | $233K | -24.8% |
| Nov 12SEC | TRDAEntrada Therapeutics, Inc. | Buy | 7,321377,899 held (+2%) | $7.73 | $57K | -26.6% |
| Nov 12SEC | TRDAEntrada Therapeutics, Inc. | Buy | 80,8814,653,430 held (+2%) | $7.73 | $625K | -26.6% |
| Nov 12SEC | TRDAEntrada Therapeutics, Inc. | Buy | 1,040378,939 held (+0%) | $7.95 | $8K | -28.7% |
| Nov 12SEC | TRDAEntrada Therapeutics, Inc. | Buy | 11,4944,664,924 held (+0%) | $7.95 | $91K | -28.7% |
- Buy
Director Baker Bros. Advisors (Gp) Llc bought $52K of KOD at $61.21 — first open-market purchase in our records.
- Buy
Director Baker Bros. Advisors (Gp) Llc bought $878K of KOD at $61.21 — largest purchase by this insider in our records.
- Buy
Director Baker Bros. Advisors (Gp) Llc bought $2.7M of KOD at $68.96 — largest purchase by this insider in our records.
- Buy
Director Baker Bros. Advisors (Gp) Llc bought $20.2M of KOD at $72.39 — largest purchase by this insider in our records.
- Buy
10% Owner Baker Bros. Advisors (Gp) Llc bought $17K of TRDA at $7.21 — first open-market purchase in our records.
- Buy
10% Owner Baker Bros. Advisors (Gp) Llc bought $183K of TRDA at $7.21 — largest purchase by this insider in our records.